Search results

We focus our efforts on supporting injection devices, medical devices, IVD, combination product developments and compliance projects for our pharmaceutical and biotech clients, who either lack resources familiar with medical device development or wish to complement their existing resources.

EffRx Pharmaceuticals SA is a commercial-stage pharmaceutical company, based in Switzerland, that develops and commercializes prescription medications for specialty indications. The primary focus is on therapeutics for men and women with musculoskeletal, genitourinary and rare diseases. Abiogen Pharma acquire

IDEOGEN Group is a family owned Swiss pharmaceutical group, providing global access to specialty medicines for unmet medical needs. We specialize in the commercialization of specialty medicines in Europe with challenging and evolving healthcare dynamics.

Pureos Bioventures is a venture capital fund to exclusively invest in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. For more information: www.pureosbio.com

Umlaut.bio develops first-in-biology small molecules focusing on tRNAs that protect signalling transduction mRNAs from degradation. Addressing this previously undrugged fundamental biochemical principle  could be able to selectively prevent the growth of cancer as well as  proinflammatory cells.

valuationLAB AG is an independent life science research boutique. Our aim is to unlock value by translating complicated science into easy-to-understand financial forecasts and valuations, and sharing this with investors.